Cohort 9

Ardiyon Bio

WEBSITE

Ardiyon Bio is an early-stage biotechnology company developing a novel PEGylated DNASE1L3 enzyme replacement therapy for systemic lupus erythematosus (SLE) and related autoimmune diseases. Their non-immunosuppressive therapeutic approach is designed to restore physiological DNA clearance while overcoming durability and immunogenicity challenges associated with existing treatments. The company is focused on improving outcomes for lupus patients with high unmet medical needs.

Highlight Video

 

The Team

Dr. Jon McCord, Founder

Dr. Bryan Sutton, Founder

Dr. Peter Keyel, Founder

 

The Mentors

Phil Sizer, Lead

Werner Kuhr

Sanda Ryan

Lena Zappia

Gipsy Bocanegra

Jay Nadkarni, Speciality

Sarah Llamas, Speciality

Nick Bergfeld, Executive Coach